Related Experiment Video
Updated: May 31, 2026
12:53
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Chlamydia trachomatis vaccine research through the years
Katelijn Schautteet1, Evelien De Clercq, Daisy Vanrompay
1Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium. katelijn.schautteet@ugent.be
Infectious Diseases in Obstetrics and Gynecology
|July 13, 2011
Summary
Developing a Chlamydia trachomatis vaccine is crucial for global health. This review examines past efforts to create an effective vaccine against this common bacterial sexually transmitted infection.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Chlamydia trachomatis is a leading cause of bacterial sexually transmitted infections (STIs) globally.
- Over 90 million new genital C. trachomatis infections are estimated annually.
- Vaccination is considered the most effective strategy for controlling C. trachomatis infections.
Observation:
- Despite extensive research, no effective vaccine currently exists for genital C. trachomatis infections.
- Numerous attempts have been made over the years to develop such a vaccine.
- This paper reviews the historical efforts in C. trachomatis vaccine development.
Findings:
- The review synthesizes data from various vaccine development strategies.
- It highlights challenges and successes in preclinical and clinical trials.
- Key vaccine candidates and their immunogenic properties are discussed.
Implications:
- Understanding past vaccine development failures is critical for future research.
- Successful C. trachomatis vaccine development could significantly reduce global STI prevalence.
- This review provides insights for designing next-generation C. trachomatis vaccines.
Related Concept Videos
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
01:29Bacterial Phylum Chlamydiae
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:51Vaccinations
Overview
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:20Chickenpox
Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...